King’s College Hospital NHS Foundation Trust has become one of the first trusts in the UK to use the newly launched Apple Watch as part of patient care.
A limited number of cancer patients at the London trust will have access to an Apple Watch app developed by tech company Medopad to support their chemotherapy.
The company said the oncology app was developed with input from doctors at King’s College Hospital and features several capabilities mainly focused on improving patient adherence to medicines.
The app also allows patients to record their temperature and any symptoms if they have a negative experience with a medicine. This data is sent instantly to a doctor’s Medopad platform on their iPad.
The aim is to allow doctors to adjust drug regimens when they are required, helping to personalise chemotherapy care and reduce side effects.